National Comprehensive Cancer Network

NCCN Compendium®
About the NCCN Compendium®
NCCN Compendium™ Chapters By Disease
Transparency: Process and Recommendations
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

NCCN Guidelines® & Clinical Resources

NCCN Drug and Biologics Compendium - Panel Members

Professionals


Go back to previous page

 

 

   
 

NCCN Drugs & Biologics Compendium

NCCN Bladder Cancer Panel Members

These chapters of the NCCN Drugs & Biologics Compendium™ were developed directly from the NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer.

These guidelines were developed by the following NCCN Bladder Cancer Panel Members.

James E. Montie, MD/Co-Chair
University of Michigan Comprehensive Cancer Center
Bladder Cancer

Peter E. Clark, MD/Co-Chair
Vanderbilt-Ingram Cancer Center
Bladder Cancer

Mario A. Eisenberger, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Bladder Cancer

Rizk El-Galley, MD
University of Alabama at Birmingham Comprehensive Cancer Center
Bladder Cancer

Richard E. Greenberg, MD
Fox Chase Cancer Center
Bladder Cancer

Harry W. Herr, MD
Memorial Sloan-Kettering Cancer Center
Bladder Cancer

Gary R. Hudes, MD
Fox Chase Cancer Center
Bladder Cancer

Deborah A. Kuban, MD
The University of Texas MD Anderson Cancer Center
Bladder Cancer

Subodh M. Lele
UNMC Eppley Cancer Center at The Nebraska Medical Center
Bladder Cancer

Jeffrey Michalski, MD, MBA
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Bladder Cancer

Anthony Patterson, MD
St. Jude Children's Research Hospital/University of Tennessee Cancer Institute
Bladder Cancer

Kamal S. Pohar, MD
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research Institute
Bladder Cancer

Michael P. Porter, MD, MS
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Bladder Cancer

Jerome P. Richie, MD
Dana-Farber/Brigham and Women's Cancer Center
Bladder Cancer

Wade J. Sexton, MD
H. Lee Moffitt Cancer Center & Research Institute
Bladder Cancer

William U. Shipley, MD
Massachusetts General Hospital Cancer Center
Bladder Cancer

Eric J. Small, MD
UCSF Helen Diller Family Comprehensive Cancer Center
Bladder Cancer

Donald L. Trump, MD
Roswell Park Cancer Institute
Bladder Cancer

Phillip J. Walther, MD, PhD
Duke Comprehensive Cancer Center
Bladder Cancer

Timothy G. Wilson, MD
City of Hope Comprehensive Cancer Center
Bladder Cancer

 
 
 

Disclosures for the NCCN Bladder Cancer Guidelines Panel